239 related articles for article (PubMed ID: 26214469)
1. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
Wang XW; Xu YH
Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
[TBL] [Abstract][Full Text] [Related]
2. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
4. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
5. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.
Krishna Narla R; Navara C; Sarquis M; Uckun FM
Leuk Lymphoma; 2001 May; 41(5-6):615-23. PubMed ID: 11378579
[TBL] [Abstract][Full Text] [Related]
7. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases.
Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J
Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892
[TBL] [Abstract][Full Text] [Related]
8. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
[TBL] [Abstract][Full Text] [Related]
9. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
Tiensiwakul P
Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis.
Lu Y; Xu YB; Yuan TT; Song MG; Lübbert M; Fliegauf M; Chen GQ
Leukemia; 2006 Jun; 20(6):987-93. PubMed ID: 16598301
[TBL] [Abstract][Full Text] [Related]
12. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
13. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
[TBL] [Abstract][Full Text] [Related]
15. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.
Diakos C; Zhong S; Xiao Y; Zhou M; Vasconcelos GM; Krapf G; Yeh RF; Zheng S; Kang M; Wiencke JK; Pombo-de-Oliveira MS; Panzer-Grümayer R; Wiemels JL
Blood; 2010 Dec; 116(23):4885-93. PubMed ID: 20807887
[TBL] [Abstract][Full Text] [Related]
16. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
de Laurentiis A; Hiscott J; Alcalay M
Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
18. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
[TBL] [Abstract][Full Text] [Related]
19. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
[TBL] [Abstract][Full Text] [Related]
20. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]